[Ivermectin]
- PMID: 15318139
- DOI: 10.1016/s0151-9638(04)93668-x
[Ivermectin]
Abstract
Ivermectin is a semi-synthetic derivative of a macrocyclic lactone. It causes paralysis in many nematodes and arthropodes because of its effect on ion-channels in cell membranes. Ivermectin was first used in veterinary medicine. In man, it was shown to be microfilaricid against Onchocerca volvulus. Most of the adverse reactions following treatment were mild, without the systemic and ocular side effects usually complicating diethylcarbamazine therapy. In endemic areas after repeated administration of ivermectin, a dramatic reduction in dermal microfilarial load was observed, resulting in a decrease in transmission. There was a significant decrease in the prevalence of anterior segment lesions in the eyes and acute onchocercal skin disease. Moreover, ivermectin also exhibited microfilaricidal activity against Wuchereria bancrofti and Brugia malayi. Annual mass treatment with a single dose of diethylcarbamazine alone, or associated with ivermectin, was initiated in endemic areas for lymphatic filariasis. The preliminary results showed a decrease in the reservoir of microfilariae and rate of transmission, a reduction in the frequency of clinical lymphatic abnormalities due to bancroftan filariasis. In Loa loa infections ivermectin decreases microfilaremia, but serious adverse events such as encephalopathy can be induced in patients with high rate of microfilaremia. Ivermectin appears to be the drug of choice in Strongyloides stercoralis infections, a single dose is highly effective with less frequent side effects than thiabendazole. Oral ivermectin is an alternative to topical scabicides, it appears as effective as local treatment for common scabies, but there are few comparative studies. The best indications for ivermectin in this ectoparasitic infection could be the outbreak in institutions and crusty scabies, but in association with topical treatment. The precise position of this agent in the treatment of scabies remains to be specified. Ivermectin is also affective in the treatment of ascariasis and cutaneous larva migrans. It could also be a promising treatment for head lice.
Similar articles
-
Ivermectin: pharmacology and application in dermatology.Int J Dermatol. 2005 Dec;44(12):981-8. doi: 10.1111/j.1365-4632.2004.02253.x. Int J Dermatol. 2005. PMID: 16409259 Review.
-
Ivermectin in human medicine.J Antimicrob Chemother. 1994 Aug;34(2):195-203. doi: 10.1093/jac/34.2.195. J Antimicrob Chemother. 1994. PMID: 7814280 Review.
-
[New indications of ivermectin].Rev Med Interne. 2001 Apr;22(4):379-84. doi: 10.1016/s0248-8663(01)00350-2. Rev Med Interne. 2001. PMID: 11586522 Review. French.
-
Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes.Lancet. 1998 Jan 17;351(9097):162-8. doi: 10.1016/S0140-6736(97)07081-5. Lancet. 1998. PMID: 9449870 Clinical Trial.
-
Single versus repeated doses of ivermectin and diethylcarbamazine for the treatment of Wuchereria bancrofti var. pacifica microfilaremia. Results at 12 months of a double-blind study.Trop Med Parasitol. 1991 Dec;42(4):335-8. Trop Med Parasitol. 1991. PMID: 1796228 Clinical Trial.
Cited by
-
Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment.J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22. J Cell Physiol. 2021. PMID: 32959892 Free PMC article.
-
One Year of Coronavirus Disease 2019 (COVID-19) in Brazil: A Political and Social Overview.Ann Glob Health. 2021 May 18;87(1):44. doi: 10.5334/aogh.3182. Ann Glob Health. 2021. PMID: 34046307 Free PMC article. Review.
-
Scabies: diagnosis and treatment.BMJ. 2005 Sep 17;331(7517):619-22. doi: 10.1136/bmj.331.7517.619. BMJ. 2005. PMID: 16166133 Free PMC article. Review. No abstract available.
-
Successful management of poisoning with ivermectin (Mectizan) in the Obala health district (Centre Region, Cameroon): a case report.J Med Case Rep. 2023 Apr 17;17(1):141. doi: 10.1186/s13256-023-03891-4. J Med Case Rep. 2023. PMID: 37062821 Free PMC article.
-
More common skin infections in children.BMJ. 2005 May 21;330(7501):1194-8. doi: 10.1136/bmj.330.7501.1194. BMJ. 2005. PMID: 15905257 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources